Bone Biologics Corp Contracts & Agreements

Form of New Warrant dated August 2, 2024 (Filed With SEC on August 2, 2024)

Form of Placement Agent Warrant dated August 2, 2024 (Filed With SEC on August 2, 2024)

Form of Inducement Letter Agreement dated August 1, 2024 (Filed With SEC on August 2, 2024)

Amended and Restated Employment Agreement, dated January 1, 2024, by and between Bone Biologics Corporation and Jeffrey Frelick (Filed With SEC on May 14, 2024)

Amendment No. 1 to Employment Agreement dated December 17, 2021 between the Company and Deina Walsh (Filed With SEC on May 14, 2024)

Form of Warrant dated March 6, 2024 (Filed With SEC on March 6, 2024)

Form of Pre-Funded Warrant dated March 6, 2024 (Filed With SEC on March 6, 2024)

Form of Placement Agent Warrant dated March 6, 2024 (Filed With SEC on March 6, 2024)

Form of Securities Purchase Agreement dated March 4, 2024 (Filed With SEC on March 6, 2024)

Engagement Agreement between H.C. Wainwright & Co., LLC and the Company dated October 30, 2023 (Filed With SEC on February 26, 2024)

Amendment No. 1 to Engagement Agreement between H.C. Wainwright & Co., LLC and the Company dated February 6, 2024 (Filed With SEC on February 26, 2024)

Form of Warrant (Filed With SEC on February 23, 2024)

Form of Pre-Funded Warrant (Filed With SEC on February 23, 2024)

Form of Placement Agent Warrant (Filed With SEC on February 23, 2024)

Form of Securities Purchase Agreement (Filed With SEC on February 23, 2024)

Form of Warrant (October 2021) (Filed With SEC on January 30, 2024)

Form of Series A Warrant (October 2022) (Filed With SEC on January 30, 2024)

Form of Series B Warrant (October 2022) (Filed With SEC on January 30, 2024)

Form of Series C Warrant (October 2022) (Filed With SEC on January 30, 2024)

Form of Indemnification Agreement (Filed With SEC on January 30, 2024)

Form of Warrant (Filed With SEC on November 20, 2023)

Form of Placement Agent Warrant (Filed With SEC on November 20, 2023)

Form of Securities Purchase Agreement (Filed With SEC on November 20, 2023)

Underwriting Agreement, dated as of June 14, 2023, between the Company and EF Hutton, division of Benchmark Investments, LLC (Filed With SEC on June 16, 2023)

Underwriting Agreement (Filed With SEC on June 13, 2023)

Form of Pre-Funded Warrant (Filed With SEC on June 13, 2023)

Underwriting Agreement (Filed With SEC on June 6, 2023)

Form of Pre-Funded Warrant (Filed With SEC on June 6, 2023)

Form of Series D Warrant (Filed With SEC on May 1, 2023)

Form of Pre-funded Warrant (Filed With SEC on May 1, 2023)

Form of Series A Warrant (Filed With SEC on October 13, 2022)

Form of Series B Warrant (Filed With SEC on October 13, 2022)

Form of Series C Warrant (Filed With SEC on October 13, 2022)

Underwriting Agreement, dated as of October 7, 2022, between the Company and WallachBeth, LLC (Filed With SEC on October 11, 2022)

Warrant Agency Agreement, dated as of October 7, 2022, between the Company and Equiniti including the Forms of Warrants (Filed With SEC on October 11, 2022)

Underwriting Agreement (Filed With SEC on October 5, 2022)

Warrant Agent Agreement including Form of Series A Warrant, Form of Series B Warrant and Form of Series C Warrant between the Company and Equiniti (Filed With SEC on October 5, 2022)

Underwriting Agreement (Filed With SEC on October 4, 2022)

Warrant Agent Agreement including Form of Series A Warrant, Form of Series B Warrant and Form of Series C Warrant between the Company and Equiniti (Filed With SEC on October 4, 2022)

Underwriting Agreement (Filed With SEC on September 23, 2022)

Warrant Agent Agreement including Form of Series A Warrant, Form of Series B Warrant and Form of Series C Warrant between the Company and Equiniti (Filed With SEC on September 23, 2022)

Third Amendment to the Amended License Agreement between the Company and UCLA TDG, dated May 9, 2022 (Filed With SEC on June 9, 2022)

Debt Conversion Agreement dated October 8, 2021 between the Company and Hankey Capital (Filed With SEC on March 15, 2022)

Supply and Development Support Agreement dated March 3, 2022 between the Company and Musculoskeletal Transplant Foundation, Inc (Filed With SEC on March 15, 2022)

Employment Agreement dated December 17, 2021 (Filed With SEC on December 22, 2021)

Form of Warrant (Filed With SEC on October 19, 2021)

Underwriting Agreement, dated as of October 13, between the Company and WallachBeth, LLC (Filed With SEC on October 15, 2021)

Warrant Agency Agreement, dated as of October 13,2021, between the Company and Equiniti including the form of Warrant (Filed With SEC on October 15, 2021)

Amendment dated November 7, 2020 to the following Convertible Promissory Notes: (a) Note dated October 24, 2014, as amended, in the principal amount of 000,000; (b) Note dated May... (Filed With SEC on October 7, 2021)

First Amendment to the Amended and Restated License Agreement dated August 13, 2020 between the Company and the Regents of the University of California (Filed With SEC on October 7, 2021)

Warrant Agent Agreement between the Company and Equiniti (Filed With SEC on October 7, 2021)

Underwriting Agreement (Filed With SEC on October 6, 2021)

Note Purchase Agreement dated June 2, 2021 (Filed With SEC on June 7, 2021)

Convertible Secured Term Note dated June 2, 2021 (Filed With SEC on June 7, 2021)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 15, 2021)

Amendment dated November 7, 2020 to the following Convertible Promissory Notes: (a) Note dated October 24, 2014, as amended, in the principal amount of 5,000,000; (b) Note dated... (Filed With SEC on April 15, 2021)

First Amendment to the Amended and Restated License Agreement dated August 13, 2020 between the Company and the Regents of the University of California (Filed With SEC on April 15, 2021)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 30, 2020)

Amendment dated November 7, 2019 to the following Convertible Promissory Notes: (a) Note dated October 24, 2014, as amended, in the principal amount of 000,000; (b) Note dated May... (Filed With SEC on March 30, 2020)

Amendment dated November 7, 2019 to the following Convertible Promissory Notes: (a) Note dated October 24, 2014, as amended, in the principal amount of 000,000; (b) Note dated May... (Filed With SEC on November 14, 2019)

Note Purchase Agreement dated September 19, 2019 (Filed With SEC on September 25, 2019)

Convertible Secured Term Note dated September 19, 2019 (Filed With SEC on September 25, 2019)

Independent Contractor Agreement dated as of June 28, 2019 between the Company and Stephen LaNeve (Filed With SEC on June 28, 2019)

Independent Contractor Agreement dated as of June 28, 2019 between the Company and Deina Walsh (Filed With SEC on June 28, 2019)

Amended and Restated Exclusive License Agreement, dated as of March 21, 2019, by and between the Company and The Regents of the University of California (Filed With SEC on April 16, 2019)

Amendment to Securities Purchase Agreement dated as of July 16, 2018 between the Company and Hankey Capital (Filed With SEC on July 19, 2018)

Securities Purchase Agreement with Hankey Capital, LLC dated as of June 11, 2018 (Filed With SEC on June 12, 2018)

Form of Convertible Secured Note (Filed With SEC on June 12, 2018)

Second Amendment to Convertible Secured Term Note (October 24, 2014 Note) with Hankey Capital, LLC dated as of June 11, 2018 (Filed With SEC on June 12, 2018)

Second Amendment to Convertible Secured Term Note (May 4, 2015 Note) with Hankey Capital, LLC dated as of June 11, 2018 (Filed With SEC on June 12, 2018)

First Amendment to Convertible Secured Term Note (February 24, 2016 Note) with Hankey Capital, LLC dated as of June 11, 2018 (Filed With SEC on June 12, 2018)

Note Purchase Agreement with Hankey Capital, LLC dated as of May 14, 2018 (Filed With SEC on May 15, 2018)

Bone Biologics Corporation Note issued to Hankey Capital on May 14, 2018 (Filed With SEC on May 15, 2018)

Subscription Agreement dated as of March 26, 2018 with Orthofix Holdings, Inc (Filed With SEC on March 29, 2018)

NOTEPURCHASE AGREEMENT (Filed With SEC on August 23, 2017)

BONEBIOLOGICS CORPORATION SECUREDCONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 23, 2017)

SUBSCRIPTION AGREEMENT (Filed With SEC on August 23, 2017)

AMENDEDAND RESTATED EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on August 23, 2017)

NOTEPURCHASE AGREEMENT (Filed With SEC on February 13, 2017)

BONEBIOLOGICS CORPORATION SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 13, 2017)

BONEBIOLOGICS CORPORATION SECURED SUBORDINATED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 13, 2017)

AMENDMENTTO SECURED CONVERTIBLE PROMISSORY NOTES (Filed With SEC on January 24, 2017)

NOTEPURCHASE AGREEMENT (Filed With SEC on October 18, 2016)

BONEBIOLOGICS CORPORATION SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 18, 2016)

BONEBIOLOGICS CORPORATION SECURED SUBORDINATED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 18, 2016)

TENTHAMENDMENT TO THE LICENSE AGREEMENT UCControl Number 2006-03-0536 (Filed With SEC on June 14, 2016)

AFHHOLDING & ADVISORY, LLC CONSULTING AGREEMENT (Filed With SEC on April 8, 2016)

BoneBiologics Corporation 321Columbus Ave. Boston,MA 02116 (Filed With SEC on March 15, 2016)

SUBSCRIPTIONAGREEMENT (Filed With SEC on February 26, 2016)

OptionAgreement for the Distribution and Supply of Sygnal™ (Filed With SEC on February 26, 2016)

CONVERTIBLESECURED TERM NOTE (Filed With SEC on February 26, 2016)

BONE BIOLOGICS, CORP. Common Stock PurchaseWarrant (Filed With SEC on February 26, 2016)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on February 26, 2016)

Sincerely, (Filed With SEC on February 16, 2016)

321Columbus Ave., Suite 300, Boston, MA 02116 (Filed With SEC on February 16, 2016)

PROFESSIONAL SERVICES AGREEMENT (Filed With SEC on January 11, 2016)

BoneBiologics Corporation Non-EmployeeDirector Compensation Policy Adoptedand effective on: [______], 2015 (Filed With SEC on January 4, 2016)

MANAGEMENTCONSULTING AGREEMENT AMENDMENT (Filed With SEC on January 4, 2016)

BoneBiologics Corporation 2015Equity Incentive Plan Adoptedby the Board of Directors: December 28, 2015 Approvedby the Stockholders: December 30, 2015 Effectivedate: December 28,... (Filed With SEC on January 4, 2016)

BoneBiologics Corporation Stock Option Grant Notice (2015 Equity Incentive Plan) (Filed With SEC on January 4, 2016)

BoneBiologics Corporation RestrictedStock Unit Grant Notice (2015 Equity Incentive Plan) (Filed With SEC on January 4, 2016)

NINTHAMENDMENT TO THE LICENSE AGREEMENT UC Control No. 2006-03-0536 (Filed With SEC on December 30, 2015)

IndependentContractor Agreement (Filed With SEC on November 16, 2015)

[Remainderof page intentionally left blank] (Filed With SEC on November 13, 2015)

BONEBIOLOGICS CORPORATION (Filed With SEC on October 8, 2015)

BoneBiologics Corporation (Filed With SEC on August 14, 2015)

CONVERTIBLESECURED TERM NOTE (Filed With SEC on May 6, 2015)

BONEBIOLOGICS, CORP. CommonStock Purchase Warrant (Filed With SEC on May 6, 2015)

Bone Biologics Corp 125May St., Suite 400 Edison,NJ 08837 (Filed With SEC on December 1, 2014)

CHIEFFINANCIAL OFFICER EMPLOYMENT AGREEMENT (Filed With SEC on November 12, 2014)

CONVERTIBLESECURED TERM NOTE (Filed With SEC on October 30, 2014)

BONEBIOLOGICS, CORP. CommonStock Purchase Warrant (Filed With SEC on October 30, 2014)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on October 30, 2014)

AGREEMENTAND PLAN OF MERGER BYAND AMONG: AFHACQUISITION X, INC., BONEBIOLOGICS ACQUISITION CORP. AND BONEBIOLOGICS, INC. September19, 2014 (Filed With SEC on September 25, 2014)

AGREEMENT OF MERGER (Filed With SEC on September 25, 2014)

BONEBIOLOGICS, INC. WARRANTTO PURCHASE COMMON STOCK (Filed With SEC on September 25, 2014)

BONEBIOLOGICS, INC. AMENDMENTNO. 1 TO WARRANTS TO PURCHASE COMMON STOCK (Filed With SEC on September 25, 2014)

BONEBIOLOGICS, INC. CommonStock Purchase Warrant (Filed With SEC on September 25, 2014)

Number of shares of Warrant Stock: 118,383 (subject to adjustment) (Filed With SEC on September 25, 2014)

BONEBIOLOGICS, INC. CommonStock Purchase Warrant (Filed With SEC on September 25, 2014)

Number of Shares: 119,318 (subject to adjustment) (Filed With SEC on September 25, 2014)

BONEBIOLOGICS, INC. CommonStock Purchase Warrant (Filed With SEC on September 25, 2014)

BONEBIOLOGICS, INC. WARRANTTO PURCHASE COMMON STOCK (Filed With SEC on September 25, 2014)

BONEBIOLOGICS, INC. CommonStock Purchase Warrant (Filed With SEC on September 25, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 25, 2014)

BONEBIOLOGICS, CORP. CONVERTIBLENOTE PURCHASE AGREEMENT (Filed With SEC on September 25, 2014)

THESECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FORINVESTMENT AND NOT WITH A VIEW TO, OR IN... (Filed With SEC on September 25, 2014)

PROMISSORYNOTE (Secured) (Filed With SEC on September 25, 2014)

DATEDthis 15th day of September 2014 MUSCULOSKELETALTRANSPLANT FOUNDATION, INC. AND BONEBIOLOGICS, INC. (Filed With SEC on September 25, 2014)

PROMISSORYNOTE (Filed With SEC on September 25, 2014)

CERTIFIEDTRUE COPY (Filed With SEC on September 25, 2014)

RETURNTO TREASURY AGREEMENT (Filed With SEC on September 25, 2014)

MembersFINRA & SIPC 590Madison Ave. 34th Fl. New York, NY 10022 Phone1 ###-###-#### http://forefrontcapitalmarkets.com (Filed With SEC on September 25, 2014)

BoneBiologics, Corp. 100Rancho Rd., Suite 7 - 231 ThousandOaks, CA 91362 (Filed With SEC on September 25, 2014)

Bone Biologies, Corp. 175 May St. Suite 400 Edison, NJ 08837 (Filed With SEC on September 25, 2014)

Bone Biologics, Corp. 100 Rancho Rd., Suite 7 - 231 Thousand Oaks, CA 91362 (Filed With SEC on September 25, 2014)

Bone Biologics, Corp. 100Rancho Rd., Suite 7 - 231 ThousandOaks, CA 91362 (Filed With SEC on September 25, 2014)

BoneBiologics, Corp. 100Rancho Rd., Suite 7 - 231 ThousandOaks, CA 91362 (Filed With SEC on September 25, 2014)

Bone Biologics, Corp. 100 Rancho Rd., Suite 7 - 231 Thousand Oaks, CA 91362 (Filed With SEC on September 25, 2014)

MANAGEMENT CONSULTING AGREEMENT (Filed With SEC on September 25, 2014)

MANAGEMENTCONSULTING AGREEMENT (Filed With SEC on September 25, 2014)

PRESIDENTAND CHIEF TECHNOLOGY OFFICER EMPLOYMENT AGREEMENT (Filed With SEC on September 25, 2014)

MANAGEMENT CONSULTING AGREEMENT (Filed With SEC on September 25, 2014)

CONSULTINGAGREEMENT (Filed With SEC on September 25, 2014)

BONEBIOLOGICS, CORP. 2014STOCK PLAN (Filed With SEC on September 25, 2014)

BONEBIOLOGICS, CORP. NOTICEOF GRANT OF STOCK OPTION (Filed With SEC on September 25, 2014)

EXCLUSIVE LICENSEAGREEMENT Between THEREGENTS OF THE UNIVERSITYOF CALIFORNIA And BONEBIOLOGICS, INC. “NELL-1Enhanced Bone Mineralization” and NELL1 ExpressionSystems and... (Filed With SEC on September 25, 2014)

INDEMNIFICATIONAGREEMENT (Filed With SEC on September 25, 2014)

FORMEROFFICER & DIRECTOR INDEMNIFICATION AGREEMENT (Filed With SEC on September 25, 2014)

Category

Industry

Companies

Contracts

Bone Biologics Corp Contracts & Agreements